| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/31/2004 | US6785613 Selection of target segments within target genes using a correspondence regime between different triplets of three bases and the three possible positions of a triplet within a nine-base site; a computer program product |
| 08/31/2004 | US6784346 Value-added traits in grain and seed transformed with thioredoxin |
| 08/31/2004 | US6784341 Defense-related signaling genes and methods of use |
| 08/31/2004 | US6784339 By introducing cdna in antisense orientation under regulation of tissue specific promoter; for plants having greater reserve materials (carbohydrates, proteins, fats) without overexpression or phenotype impairment |
| 08/31/2004 | US6784337 Method of improving nematode resistance in plants via transformation with a DNA encoding a proteinase inhibitor fusion protein |
| 08/31/2004 | US6784335 Targeting construct comprising first and second polynucleotide sequences homologous to a bmp gene, and a selectable marker; animal models; bone morphogenetic proteins (bmp) |
| 08/31/2004 | US6784290 Antisense oligonucleotide inhibition of ras |
| 08/31/2004 | US6784285 Kinases; for making angiogenisis inhibitors; drug screening |
| 08/31/2004 | US6784284 Polypeptide for use in treatment of bone and cell proliferation disorders |
| 08/31/2004 | US6784283 Peptide antibiotics |
| 08/31/2004 | US6784164 Choline binding proteins for anti-pneumococcal vaccines |
| 08/31/2004 | US6784163 Inhibition of cationic amino acid transporter protein and uses thereof |
| 08/31/2004 | US6784157 Peptide activates dna binding of wild-type p53 or a p53 mutant containing a single amino acid substitution; a peptidomimetic consisting of four sequential amino acids from a negative regulatory region; anticarcinogenic, -tumor agents |
| 08/31/2004 | US6784155 Contacting hematopoietic cells with a stem cell proliferation stimulating amount of inprol or an opiate compound or a combination of inprol and an opiate compound |
| 08/31/2004 | US6784153 Identify molecules that can bind to organ or tissue specific markers and, therefore, can home to the organ or tissue; membrane dipeptidase (mdp)-binding homing molecule, which is a molecule that selectively homes to lung endothelium |
| 08/31/2004 | US6783985 Identification of antifungal drug target genes; strain of diploid fungal cells in which both alleles of a gene are modified |
| 08/31/2004 | US6783982 Proteins related to neuronal regeneration and uses thereof |
| 08/31/2004 | US6783980 Nucleotide sequences for use in the generation of gene transfer tools |
| 08/31/2004 | US6783973 For in vitro agonist and antagonist screening |
| 08/31/2004 | US6783969 Microarrays for diagnosis, therapy and research |
| 08/31/2004 | US6783967 Which encode the beta-subunit of rna polymerase b |
| 08/31/2004 | US6783961 Used in diagnostic, forensic, gene therapy, and chromosome mapping; for making expression and secretion vectors |
| 08/31/2004 | US6783960 Polypeptide for use in the treatment of thrombosis and sepsis |
| 08/31/2004 | US6783959 Cd antigens for diagnosis/therapy |
| 08/31/2004 | US6783958 Generating biosensor protein; determine sequence of fluorescent protein, generate fusion protein, incubate with modulator, detect conformational adjustments, monitor adjustments in fluorescence |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783954 VEGF nucleic acid and amino acid sequences |
| 08/31/2004 | US6783953 For prevention and treatment of angiogenesis |
| 08/31/2004 | US6783952 Deleting portion of eukaryotic nucleotide sequence encoding cerebral cortical voltage-dependent calcium channel alpha 2 subunit yielding soluble secreted protein retaining affinity for (3h)gabapentin |
| 08/31/2004 | US6783945 Cloning and uses of the genetic locus bcl-6 |
| 08/31/2004 | US6783939 Alphavirus vectors and virosomes with modified HIV genes for use in vaccines |
| 08/31/2004 | US6783936 Antigenic epitopes with Lym-1 reactivity and uses thereof |
| 08/31/2004 | US6783933 Calcium channel modulators (cacna1g); for detecting cellular proliferative disorders by determining the methylation state of genes or regulatory regions |
| 08/31/2004 | US6783930 Development of novel anti-microbial agents based on bacteriophage genomics |
| 08/31/2004 | US6783775 Comprising ceruloplasmin and a serum-derived composition (sdf) having a low molecular weight, electrically charged at acidic ph and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 08/31/2004 | US6783764 Comprising purified apxiv toxin and a pharmaceutically acceptable carrier |
| 08/31/2004 | US6783763 Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines |
| 08/31/2004 | US6783761 Hormone inhibitors for inducing antibodies against gonadotropin-releasing hormone, comprises fusion peptide of helper t-cell peptide epitope and immunomimic peptide epitope |
| 08/31/2004 | US6783759 Compositions and methods for modulating variola virus |
| 08/31/2004 | US6783758 Diagnosis and treatment of malignant neoplasms |
| 08/31/2004 | CA2194369C Methods and compositions for the specific coagulation of vasculature |
| 08/31/2004 | CA2061362C Method for producing human nerve growth factor-2 |
| 08/26/2004 | WO2004072641A1 Compositions and methods for enhancing apoptosis |
| 08/26/2004 | WO2004072605A2 Method for the characterization of proteins, isolated proteins and uses therefore |
| 08/26/2004 | WO2004072305A2 Atlastin |
| 08/26/2004 | WO2004072303A1 Method for identification of novel virulence associated genes |
| 08/26/2004 | WO2004072296A2 Compositions for modulating immune cell activity and methods for detection thereof |
| 08/26/2004 | WO2004072287A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 08/26/2004 | WO2004072285A1 “goblin” cancer associated polypeptides, related reagents, and methods of use thereof |
| 08/26/2004 | WO2004072283A1 Antifreeze protein containing ice nucleating protein sequence |
| 08/26/2004 | WO2004072282A1 Nephropathy-associated gene |
| 08/26/2004 | WO2004072274A1 Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier |
| 08/26/2004 | WO2004072269A2 Bex4 nucleic acids, polypeptides, and method of using |
| 08/26/2004 | WO2004072268A2 Pkhdl1, a homolog of the autosomal recessive kidney disease gene |
| 08/26/2004 | WO2004072267A2 Enzymes |
| 08/26/2004 | WO2004072263A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | WO2004072260A2 Cell free assay systems for identifying a substance of interest |
| 08/26/2004 | WO2004072256A2 Variants of cytochrome c and methods of diagnostics of thrombocytopenia |
| 08/26/2004 | WO2004072253A2 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 08/26/2004 | WO2004072242A2 Screening of compounds for hematological disorder treatment |
| 08/26/2004 | WO2004072241A2 Compositions and methods for cleaving iap |
| 08/26/2004 | WO2004072240A2 Antiplasmin cleaving enzyme |
| 08/26/2004 | WO2004072239A2 Novel polypeptides with antifungal activity |
| 08/26/2004 | WO2004072233A2 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use |
| 08/26/2004 | WO2004072226A2 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells |
| 08/26/2004 | WO2004072225A2 Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi |
| 08/26/2004 | WO2004072114A1 Method of diagnosing bovince blood coagulation factor xi deficiency |
| 08/26/2004 | WO2004072113A1 Method and compositions for boosting immune response |
| 08/26/2004 | WO2004072112A2 A method for formulating mhc-like molecules for long time storage |
| 08/26/2004 | WO2004072111A2 Novel therapeutic and diagnostic apoptotic inductors |
| 08/26/2004 | WO2004072110A1 Methods for inhibiting signal transduction |
| 08/26/2004 | WO2004072109A1 Gene resistant to aphis gossypii |
| 08/26/2004 | WO2004072100A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | WO2004072099A2 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41 |
| 08/26/2004 | WO2004072098A2 Immunocompromised rodents as dual color tumor models |
| 08/26/2004 | WO2004072096A2 Peptides binding gp120 of hiv-1 |
| 08/26/2004 | WO2004072095A2 Cyclized peptides as exotoxin antagonists |
| 08/26/2004 | WO2004072094A2 Hmgb1 modulator binding domain |
| 08/26/2004 | WO2004072093A2 Antimicrobial agents from streptococcus mitis and streptococcus oralis |
| 08/26/2004 | WO2004071534A1 Preventives/remedies for kidney diseases |
| 08/26/2004 | WO2004071517A2 Uses of il-23 related reagents |
| 08/26/2004 | WO2004071493A1 Peptidic nanoparticles as drug delivery and antigen display systems |
| 08/26/2004 | WO2004071464A2 Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells |
| 08/26/2004 | WO2004071461A2 Tra16 a tr4/tr2 repressor |
| 08/26/2004 | WO2004071457A2 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | WO2004071422A2 Streptococcal serum opacity factors and fibronectin-binding proteins and peptides thereof for the treatment and detection of streptococcal infection |
| 08/26/2004 | WO2004071420A2 Compositions and methods for less immunogenic protein formulations |
| 08/26/2004 | WO2004071414A2 Therapeutic anti-hcv (al9) compounds |
| 08/26/2004 | WO2004071387A2 Hsp60 from arthrobacter |
| 08/26/2004 | WO2004058980A3 Plants having modified growth characteristics and a method for making the same |
| 08/26/2004 | WO2004048530A3 Compositions and methods for the reversible capture of biomolecules |
| 08/26/2004 | WO2004046722A3 Scd40l, papp-a and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases |
| 08/26/2004 | WO2004046315A8 Compositions and methods utilizing human gamma-hydroxybutyrate receptor |
| 08/26/2004 | WO2004045555A3 Immunogenic epitopes for fibroblast growth factor 5 (fgf-5) presented by hla-a3 and hla-a2 |
| 08/26/2004 | WO2004045529A3 West nile virus vaccine |
| 08/26/2004 | WO2004044176A3 Adenoviral vector vaccine |
| 08/26/2004 | WO2004044172A3 A method for purifying and recovering silk proteins in soluble form and uses thereof |
| 08/26/2004 | WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof |
| 08/26/2004 | WO2004044145A3 Compositions and methods for enhancing disease resistance in fish |